TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) today announced that it is taking proactive steps to capitalize on a rule which the Food and Drug Administration (“FDA”) in the United States announced plans to propose, which would establish a maximum level of nicotine in cigarettes and other combustible tobacco products. In the FDA’s announcement, the agency described the role of nicotine as an attribute of tobacco products that contributes to the addictiveness of cigarettes and that it is the “main driver of sustained use of these products [cigarettes].” “As a former smoker of tobacco cigarettes, I know that nicotine is the enemy. It is clear that the FDA is recognizing this, based on its plans to propose a rule to cap the amount of nicotine allowed in tobacco cigarettes sold in the United States,” said TAAT Founder Joe Deighan. “I expect this to cause a considerable shift in the tobacco category in the U.S., which we could capitalize on with our established offering of a nicotine-free alternative that feels substantially similar to a regular cigarette with standard levels of nicotine. We are continuing to commercialize TAAT to build upon our existing footprint of 2,700 U.S. stores, and will be taking proactive steps to take advantage of a new rule such as this if it goes into effect.”
To view the full press release, visit https://ibn.fm/KZ4Rg
About TAAT Global Alternatives Inc.
TAAT(TM) develops, manufactures and distributes alternative products in categories to include tobacco, hemp, kratom, and other emerging segments of the CPG industry. Its flagship product is a nicotine-free, tobacco-free cigarette with a patent-pending base material formulation, sold in over 2,700 U.S. stores. With over CAD $80 million in overall net revenue in 2021, TAAT(TM)’s facilities include a manufacturing plant in Nevada, as well as a distribution centre and multiple convenience stores in Ohio. For more information, please visit www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
